File: CTD
• Independently developed a complete FDA CTD submission for Ceftriaxone Sodium, demonstrating understanding
of regulatory documentation structure and requirements.
• Evaluated drug stability and shelf-life data to support regulatory quality requirements and storage conditions.
• Researched and implemented ICH, FDA, and EMA regulations to ensure compliance to global CTD standards.
• To ensure accurate representation of product lifecycle data, the Quality (CMC), Nonclinical
(toxicology/pharmacology), and Clinical (PK/PD, effectiveness, safety) sections were developed and integrated.
• Organized and formatted the submission data and documentation with professional regulatory writing practices
such as clarity, structure, and transparency.
• Strengthened expertise in regulatory affairs and technical writing, and gathered a comprehensive collection of
documents and product data to complete a mock CTD submission.
